Coming of age in cystic fibrosis – transition from paediatric to adult care

Cystic fibrosis (CF) is the most common multi-system inherited disorder, with a UK population exceeding 9,000. There have been significant improvements in CF survival over the decades, attributed to improvements in therapies available, our understanding of the disease and better organisation of care...

Full description

Saved in:
Bibliographic Details
Published in:Clinical medicine (London, England) England), 2013-10, Vol.13 (5), p.482-486
Main Authors: Nazareth, Dilip, Walshaw, Martin
Format: Article
Language:English
Subjects:
Adolescent
Adult
Biological and medical sciences
CF survival
Child
Cystic fibrosis
Cystic Fibrosis - complications
Cystic Fibrosis - epidemiology
Cystic Fibrosis - therapy
Errors of metabolism
Female
General aspects
Humans
Male
Medical sciences
Metabolic diseases
Miscellaneous hereditary metabolic disorders
Survival Analysis
transition
Transition to Adult Care
Transitional Care
United Kingdom - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c595t-e016c2cb32495ccaa497cba4074eedad79feeab51acb7384f009e7043466b26d3
cites cdi_FETCH-LOGICAL-c595t-e016c2cb32495ccaa497cba4074eedad79feeab51acb7384f009e7043466b26d3
container_end_page 486
container_issue 5
container_start_page 482
container_title Clinical medicine (London, England)
container_volume 13
creator Nazareth, Dilip
Walshaw, Martin
description Cystic fibrosis (CF) is the most common multi-system inherited disorder, with a UK population exceeding 9,000. There have been significant improvements in CF survival over the decades, attributed to improvements in therapies available, our understanding of the disease and better organisation of care. CF care providers have been early advocates for successful healthcare transition from the paediatric to adult sector and CF can be considered a model process where a paediatric disease has now become an adult one. This article looks at the transition process in CF and the future challenges CF physicians will face.
doi_str_mv 10.7861/clinmedicine.13-5-482
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4953800</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1470211824015860</els_id><sourcerecordid>1443419527</sourcerecordid><originalsourceid>FETCH-LOGICAL-c595t-e016c2cb32495ccaa497cba4074eedad79feeab51acb7384f009e7043466b26d3</originalsourceid><addsrcrecordid>eNqFkc1u1TAQhSMEoqXwCCBLCIlNin_jZEOFrviTitjA2nImk4urxL7YSaXueAfekCdhyr2UwoaVR_I358zMqarHgp_athEvYApxxiFAiHgqVG1q3co71bHQVlHZqbu_al5LIdqj6kEpF5wLo7vmfnUktRDG8ua4-rBJc4hblkbmt8hCZHBVlgBsDH1OJRT249t3tmQfS1hCimzMaWY7T85-ycQtiflhnRYGPuPD6t7op4KPDu9J9fnN60-bd_X5x7fvN6_OazCdWWrkogEJvZK6MwDe685C7zW3GnHwg-1GRN8b4aG3qtUj5x1arpVuml42gzqpXu51d2tPRwCMNOHkdjnMPl-55IP7-yeGL26bLh35qZZzEnh-EMjp64plcXMogNPkI6a1OKHJTHRGWkKf_oNepDVHWo-optVKtc21oNlTQFcrGcebYQR314G524E5oZxxFBj1Pbm9yU3X74QIeHYAfAE_jZQEhPKHs9ZIKQVxZ3sO6e6XAbMrEDACOWaExQ0p_GeUn7s2umY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1468433860</pqid></control><display><type>article</type><title>Coming of age in cystic fibrosis – transition from paediatric to adult care</title><source>Open Access: PubMed Central</source><source>ScienceDirect Journals</source><creator>Nazareth, Dilip ; Walshaw, Martin</creator><creatorcontrib>Nazareth, Dilip ; Walshaw, Martin</creatorcontrib><description>Cystic fibrosis (CF) is the most common multi-system inherited disorder, with a UK population exceeding 9,000. There have been significant improvements in CF survival over the decades, attributed to improvements in therapies available, our understanding of the disease and better organisation of care. CF care providers have been early advocates for successful healthcare transition from the paediatric to adult sector and CF can be considered a model process where a paediatric disease has now become an adult one. This article looks at the transition process in CF and the future challenges CF physicians will face.</description><identifier>ISSN: 1470-2118</identifier><identifier>EISSN: 1473-4893</identifier><identifier>DOI: 10.7861/clinmedicine.13-5-482</identifier><identifier>PMID: 24115706</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Biological and medical sciences ; CF survival ; Child ; Cystic fibrosis ; Cystic Fibrosis - complications ; Cystic Fibrosis - epidemiology ; Cystic Fibrosis - therapy ; Errors of metabolism ; Female ; General aspects ; Humans ; Male ; Medical sciences ; Metabolic diseases ; Miscellaneous hereditary metabolic disorders ; Survival Analysis ; transition ; Transition to Adult Care ; Transitional Care ; United Kingdom - epidemiology</subject><ispartof>Clinical medicine (London, England), 2013-10, Vol.13 (5), p.482-486</ispartof><rights>2013 © 2013 Royal College of Physicians</rights><rights>2014 INIST-CNRS</rights><rights>Copyright Royal College of Physicians Oct 2013</rights><rights>2013 Royal College of Physicians 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c595t-e016c2cb32495ccaa497cba4074eedad79feeab51acb7384f009e7043466b26d3</citedby><cites>FETCH-LOGICAL-c595t-e016c2cb32495ccaa497cba4074eedad79feeab51acb7384f009e7043466b26d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4953800/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1470211824015860$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27752221$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24115706$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nazareth, Dilip</creatorcontrib><creatorcontrib>Walshaw, Martin</creatorcontrib><title>Coming of age in cystic fibrosis – transition from paediatric to adult care</title><title>Clinical medicine (London, England)</title><addtitle>Clin Med (Lond)</addtitle><description>Cystic fibrosis (CF) is the most common multi-system inherited disorder, with a UK population exceeding 9,000. There have been significant improvements in CF survival over the decades, attributed to improvements in therapies available, our understanding of the disease and better organisation of care. CF care providers have been early advocates for successful healthcare transition from the paediatric to adult sector and CF can be considered a model process where a paediatric disease has now become an adult one. This article looks at the transition process in CF and the future challenges CF physicians will face.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>CF survival</subject><subject>Child</subject><subject>Cystic fibrosis</subject><subject>Cystic Fibrosis - complications</subject><subject>Cystic Fibrosis - epidemiology</subject><subject>Cystic Fibrosis - therapy</subject><subject>Errors of metabolism</subject><subject>Female</subject><subject>General aspects</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Miscellaneous hereditary metabolic disorders</subject><subject>Survival Analysis</subject><subject>transition</subject><subject>Transition to Adult Care</subject><subject>Transitional Care</subject><subject>United Kingdom - epidemiology</subject><issn>1470-2118</issn><issn>1473-4893</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1TAQhSMEoqXwCCBLCIlNin_jZEOFrviTitjA2nImk4urxL7YSaXueAfekCdhyr2UwoaVR_I358zMqarHgp_athEvYApxxiFAiHgqVG1q3co71bHQVlHZqbu_al5LIdqj6kEpF5wLo7vmfnUktRDG8ua4-rBJc4hblkbmt8hCZHBVlgBsDH1OJRT249t3tmQfS1hCimzMaWY7T85-ycQtiflhnRYGPuPD6t7op4KPDu9J9fnN60-bd_X5x7fvN6_OazCdWWrkogEJvZK6MwDe685C7zW3GnHwg-1GRN8b4aG3qtUj5x1arpVuml42gzqpXu51d2tPRwCMNOHkdjnMPl-55IP7-yeGL26bLh35qZZzEnh-EMjp64plcXMogNPkI6a1OKHJTHRGWkKf_oNepDVHWo-optVKtc21oNlTQFcrGcebYQR314G524E5oZxxFBj1Pbm9yU3X74QIeHYAfAE_jZQEhPKHs9ZIKQVxZ3sO6e6XAbMrEDACOWaExQ0p_GeUn7s2umY</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Nazareth, Dilip</creator><creator>Walshaw, Martin</creator><general>Elsevier Ltd</general><general>Royal College of Physicians</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131001</creationdate><title>Coming of age in cystic fibrosis – transition from paediatric to adult care</title><author>Nazareth, Dilip ; Walshaw, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c595t-e016c2cb32495ccaa497cba4074eedad79feeab51acb7384f009e7043466b26d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>CF survival</topic><topic>Child</topic><topic>Cystic fibrosis</topic><topic>Cystic Fibrosis - complications</topic><topic>Cystic Fibrosis - epidemiology</topic><topic>Cystic Fibrosis - therapy</topic><topic>Errors of metabolism</topic><topic>Female</topic><topic>General aspects</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Miscellaneous hereditary metabolic disorders</topic><topic>Survival Analysis</topic><topic>transition</topic><topic>Transition to Adult Care</topic><topic>Transitional Care</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nazareth, Dilip</creatorcontrib><creatorcontrib>Walshaw, Martin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>UK &amp; Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical medicine (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nazareth, Dilip</au><au>Walshaw, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coming of age in cystic fibrosis – transition from paediatric to adult care</atitle><jtitle>Clinical medicine (London, England)</jtitle><addtitle>Clin Med (Lond)</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>13</volume><issue>5</issue><spage>482</spage><epage>486</epage><pages>482-486</pages><issn>1470-2118</issn><eissn>1473-4893</eissn><abstract>Cystic fibrosis (CF) is the most common multi-system inherited disorder, with a UK population exceeding 9,000. There have been significant improvements in CF survival over the decades, attributed to improvements in therapies available, our understanding of the disease and better organisation of care. CF care providers have been early advocates for successful healthcare transition from the paediatric to adult sector and CF can be considered a model process where a paediatric disease has now become an adult one. This article looks at the transition process in CF and the future challenges CF physicians will face.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>24115706</pmid><doi>10.7861/clinmedicine.13-5-482</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1470-2118
ispartof Clinical medicine (London, England), 2013-10, Vol.13 (5), p.482-486
issn 1470-2118
1473-4893
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4953800
source Open Access: PubMed Central; ScienceDirect Journals
subjects Adolescent
Adult
Biological and medical sciences
CF survival
Child
Cystic fibrosis
Cystic Fibrosis - complications
Cystic Fibrosis - epidemiology
Cystic Fibrosis - therapy
Errors of metabolism
Female
General aspects
Humans
Male
Medical sciences
Metabolic diseases
Miscellaneous hereditary metabolic disorders
Survival Analysis
transition
Transition to Adult Care
Transitional Care
United Kingdom - epidemiology
title Coming of age in cystic fibrosis – transition from paediatric to adult care
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A58%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coming%20of%20age%20in%20cystic%20fibrosis%20%E2%80%93%20transition%20from%20paediatric%20to%20adult%20care&rft.jtitle=Clinical%20medicine%20(London,%20England)&rft.au=Nazareth,%20Dilip&rft.date=2013-10-01&rft.volume=13&rft.issue=5&rft.spage=482&rft.epage=486&rft.pages=482-486&rft.issn=1470-2118&rft.eissn=1473-4893&rft_id=info:doi/10.7861/clinmedicine.13-5-482&rft_dat=%3Cproquest_pubme%3E1443419527%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c595t-e016c2cb32495ccaa497cba4074eedad79feeab51acb7384f009e7043466b26d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1468433860&rft_id=info:pmid/24115706&rfr_iscdi=true